Rezultati

eNauka >  Results >  A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
Title: A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
Authors: Mease, P; Strand, Vibeke; Shalamberidze, L; Dimic, Aleksandar N; Raskina, T; Xu, Li-An; Liu, Y; Smith, J
Issue Date: 2012
Publication: ANNALS OF THE RHEUMATIC DISEASES
ISSN: 0003-4967 Annals of the Rheumatic Diseases Search Idenfier
Type: Article
Collation: vol. 71 br. 7 str. 1183-1189
DOI: 10.1136/annrheumdis-2011-200704
WoS-ID: 000305293400013
Scopus-ID: 2-s2.0-84862783578
URI: https://enauka.gov.rs/handle/123456789/809610
Project: Alder Biopharmaceuticals
Bristol-Myers Squibb
Abbott
Amgen
BiogenIdec
Centocor
Genentech
Lilly
Pfizer
UCB
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

91
SCOPUSTM
74
OpenCitations
79
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.